Clinical Trial Update: Constraint-Induced (CI) Movement Therapy for Progressive Multiple Sclerosis (MS) [Phase 1]

View source ↗

Summary

Phase 1 trial of constraint-induced movement therapy for progressive multiple sclerosis has completed. The study investigates CI therapy to improve upper-limb f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Snippet

Sponsor: National Multiple Sclerosis Society | Conditions: Multiple Sclerosis | Phase 1 | Status: COMPLETED